EP2631248
Treatment of tumors using specific anti-L1 antibody
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.6.2008EP published:
15.11.2017EP application number:
13000027.6
EPO information:
European Patent Register
Max expiry date:
12.6.2028
Title:
Treatment of tumors using specific anti-L1 antibody
Timeline
Today
13.6.2008EP application
15.11.2017EP Publication
Owner
Name:
Medigene AGAddress:
Lochhamer Strasse 11, 82152, Planegg/Martinsried, DE
Name:
Deutsches Krebsforschungszentrum Stiftung des öffentlichen RechtsAddress:
Im Neuenheimer Feld 280, 69120, Heidelberg, DE
Inventor
Name:
Kelm, DanielaAddress:
Steinheim an der Murr, DE
Name:
Altevogt, PeterAddress:
Neckargemünd, DE
Name:
Lüttgau, SandraAddress:
Schongau, DE
Name:
Krüger, AchimAddress:
München, DE
Name:
Moldenhauer, GerhardAddress:
Bad Arolsen, DE
Name:
Breitling, FrankAddress:
Heidelberg, DE
Name:
Bärreiter, SilkeAddress:
Weinheim, DE
Name:
Li, YiAddress:
WantageOxfordshire OX12 0LD, GB
Name:
Möbius, UlrichAddress:
Gauting, DE
Name:
Sebens, Susanne, Prof. Dr.Address:
Kiel, DE
Name:
Schäfer, Heiner, Prof. Dr.Address:
Kiel, DE
Priority
Number:
944359 PDate:
15.6.2007Country:
US
Classification
Categories:
C07K 16/28, A61K 39/00, A61N 5/02, A61N 5/06, A61K 39/395